Clinical Trials in Massachusetts

Showing 14441-14460 of 17,868 trials

Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients

NCT01363102

The investigators hypothesize that by applying a validated algorithm to accomplish early mobilization in surgical intensive care unit (ICU) patients, these patients will achieve a higher level of mobility which translates to shorter ICU length of stay and improved functional status at discharge. Additionally, the investigators hypothesize that genetic polymorphisms related to muscle strength and sleep will also explain some variance in these outcome variables.

Muscle WeaknessCritical IllnessRespiratory Insufficiency

Massachusetts General Hospital200 participantsStarted Jun 2011

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Worcester, Massachusetts, United States +2 more locations

COMPLETEDPhase 221 miles

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

NCT01684163

GLYX-13 is a NMDA receptor glycine site partial agonist being studied in subjects with major depressive disorder (depression) who have responded inadequately to another antidepressant drug during the current episode. This trial will assess the effects of GLYX-13 on depression when added to another antidepressant drug that the patient is already taking.

Major Depressive Disorder

Naurex, Inc, an affiliate of Allergan plc369 participantsStarted Nov 2012

Birmingham, Alabama, United States • Encino, California, United States • Los Alamitos, California, United States +23 more locations

Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Find Trials by Condition in Massachusetts

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Femoral Nerve Block Compared to Exparel in Total Knee Replacement

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

Sleep Disorders Management, Health and Safety in Police

Validation of Aspiration Markers

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Dietary Intake of Tryptophan and Metformin Response

Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder

Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)

fMRI Study of Expectancy on Acupuncture Treatment Outcomes in Knee OA

Increasing Physical Activity Among Inactive Bariatric Surgery Patients (Bari-Active)

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.